At present, the
quinolone antibiotics developed and put into mass production in China
mainly include norfloxacin, ciprofloxacin, ofloxacin, enoxacin,
lomefloxacin, fleroxacin, etc. Among them, the production of
norfloxacin, ciprofloxacin and ofloxacin is the largest, accounting for
98% of the total production of fluoroquinolones in China.
Quinolones
are generally synthesized from fluorobenzene ring to fluoroquinoline
compound and then condensed with piperazine (or methylpiperazine). As
China is rich in fluorite reserves, it is one of the countries with the
largest output of fluorine-containing drugs and intermediates in the
world, and more than 80% of fluorine-containing intermediates are
supplied for export. On the whole, fluorobenzene intermediates developed
earlier in China, and the current production capacity is generally
surplus; The development of trifluoromethylene intermediates is late,
and the development speed is fast in recent years; However, for
heterocyclic aromatic compounds, especially fluoropyridines, only a few
research units and manufacturers in China currently have the synthesis
technology of fluoropyridine intermediates. Therefore, fluoropyridine
intermediates will become one of the main research directions of
domestic fluoropyridine intermediates in the next few years.